100+ Free ABPath Chemical Pathology Practice Questions

Pass your American Board of Pathology Chemical Pathology Subspecialty Certification Examination exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

Varies by year Pass Rate

100+ Questions

100% Free

1 / 100

Question 1

Score: 0/0

A 55-year-old patient has a blood draw performed with a tourniquet applied for 5 minutes. Which analytes are most affected by prolonged venous stasis?

Sodium and chloride

Protein, calcium, potassium, lactate, and enzymes (CK, AST, ALT) — falsely elevated due to hemoconcentration and hemolysis

Only glucose

None

to track

2026 Statistics

Key Facts: ABPath Chemical Pathology Exam

270

Total Questions

Combined Written/Practical, 6 sections of 45

~6h 18m

Total Exam Time

One-day computer-based via Pearson VUE

$2,100

Subspecialty Exam Fee (2026)

Includes $200 non-refundable admin fee

14%

Organ Systems Weight

Largest domain on 2026 content specs

1 year

ACGME Fellowship Required

Post AP/CP or CP primary certification

Sept 8-28

2026 Exam Window

Pearson VUE Professional Testing Centers

The ABPath Chemical Pathology exam tests 270 one-best-answer questions in combined Written/Practical over ~6.3 hours in one day. The 2026 Content Specifications allocate: Organ Systems 14%, Analytes 13%, Technical Methods 11%, Electrolytes/Catecholamines/Vitamins/Porphyrins 11%, Toxicology 11%, Endocrine 11%, Reproduction/Pregnancy/Newborn 9%, Immunology 9%, Specimen Collection/Safety 6%, Lab Management 5%. Fee: $2,100. Eligibility requires ACGME 1-yr Chemical Pathology fellowship and AP/CP or CP primary certification. Exam September 8-28, 2026 via Pearson VUE.

Sample ABPath Chemical Pathology Practice Questions

Try these sample questions to test your ABPath Chemical Pathology exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 55-year-old patient has a blood draw performed with a tourniquet applied for 5 minutes. Which analytes are most affected by prolonged venous stasis?

A.Sodium and chloride

B.Protein, calcium, potassium, lactate, and enzymes (CK, AST, ALT) — falsely elevated due to hemoconcentration and hemolysis

C.Only glucose

D.None

Explanation: Tourniquet application >1 minute causes hemoconcentration (falsely elevated protein, albumin, calcium, bilirubin, lipids, enzymes) and local hypoxia driving lactate and potassium release. Recommended practice: apply tourniquet, release within 1 minute, or release briefly and reapply for better vein access. Fist pumping also falsely elevates potassium.

2A hemolyzed serum specimen will falsely ELEVATE which analytes?

A.Sodium only

B.Potassium, LDH, AST, magnesium, phosphate, and iron due to release from lysed RBCs; also interferes with bilirubin and spectrophotometric assays

C.Glucose

D.Urea

Explanation: Hemolysis releases intracellular contents of RBCs: potassium (factor ~20x higher intracellular), LDH, AST, magnesium, phosphate, iron. Free hemoglobin absorbs at 415/540/575 nm interfering with spectrophotometric assays. Serum/plasma appearance guides hemolysis index (usually reported 0-4 scale). Causes: vigorous shaking, small-bore needle, vacuum tube underfill, traumatic draw, freezing.

3A specimen collected for potassium testing was stored in EDTA tube. Result is 2.1 mEq/L. Interpretation?

A.True hypokalemia

B.Contamination/pseudohypokalemia — EDTA binds potassium, but more likely issue is contamination of sample with EDTA or sample from EDTA tube causing falsely LOW K+. Recollect in appropriate tube (red/SST for chemistry)

C.Normal potassium

D.Hyperkalemia

Explanation: Common specimen integrity issue: EDTA contamination of chemistry tube falsely LOWERS K+ (EDTA chelates K+ partially and especially calcium and magnesium — so Ca²⁺ very low, Mg²⁺ low, and K+ typically higher rather than lower due to KEDTA, so always verify tube type). Proper order of draw (sterile → blue → red/SST → green/heparin → lavender/EDTA → gray) prevents carryover. Always recollect suspicious samples.

4Pseudohyperkalemia from thrombocytosis or leukocytosis is diagnosed by:

A.Imaging

B.Comparison of plasma (heparinized) vs serum K+; higher serum K+ (due to release during clot formation) indicates pseudohyperkalemia

C.Urine K+

D.ECG

Explanation: Pseudohyperkalemia: K+ release during in-vitro clot formation in patients with very high platelet or leukocyte counts (CML, myeloma, leukemias, thrombocythemia). Serum K+ > plasma K+ by ≥0.4 mEq/L suggests pseudohyperkalemia. Solution: use plasma (heparin green top) instead of serum. Contrast with 'reverse pseudohyperkalemia' rarely seen in CML — lysis during storage releases K+.

5Universal precautions in a clinical chemistry laboratory require:

A.Only eye protection

B.Treating all specimens as potentially infectious — PPE (gloves, lab coat, eye protection), needle safety devices, no recapping, sharps containers, biosafety cabinet for aerosol-generating procedures, vaccine requirements (hepatitis B)

C.Only lab coat

D.No precautions

Explanation: Universal precautions (CDC/OSHA Bloodborne Pathogens Standard 29 CFR 1910.1030): treat all human blood and specimens as infectious. Required: PPE (gloves, lab coat, face/eye protection), engineering controls (safety needles, sharps containers, biosafety cabinets), work practice controls (no mouth pipetting, no eating in lab), exposure control plan, hepatitis B vaccination offered to employees at risk, bloodborne pathogens training annually.

6A 24-hour urine collection for catecholamine metabolites (VMA, HVA) requires:

A.No preservation

B.Acidification with 6N HCl to pH <3 to stabilize catecholamines and their metabolites; keep refrigerated during collection

C.Freezing only

D.Alkaline pH

Explanation: 24-hour urine collection preservation varies by analyte: HCl acidification for catecholamines/VMA/HVA/metanephrines (stabilizes), no preservative for 5-HIAA (dietary restrictions — serotonin-rich foods avoided 3 days), boric acid for microbiology, refrigeration for most. Patient instruction: discard first morning void, collect all subsequent voids including next morning's first void of same time, keep refrigerated. Incomplete collection (indicated by low creatinine excretion ~15-25 mg/kg body weight) invalidates.

7Beer-Lambert law in spectrophotometry states:

A.Light intensity is random

B.Absorbance (A) = ε × b × c, where ε is molar absorptivity, b is path length, c is concentration — linear relationship between A and c at appropriate concentrations

C.Path length doesn't matter

D.Concentration decreases with absorbance

Explanation: Beer-Lambert Law: A = ε × b × c (ε = molar absorptivity [L·mol⁻¹·cm⁻¹], b = path length [cm], c = concentration [mol/L]). Linear A vs c relationship fails at very high concentrations (deviations from Beer's law due to instrument limitations, chemical effects, stray light). At A >2.0, measurement becomes unreliable — dilute sample or use shorter path length. Applicable to most UV-Vis chemistry assays.

8Ion-selective electrode (ISE) for sodium uses which principle?

A.Amperometry

B.Potentiometry — glass membrane selective for Na+ generates voltage proportional to ion activity; measured against reference electrode

C.Absorbance

D.Fluorescence

Explanation: ISE (potentiometric): membrane selectively permits ion of interest; voltage difference across membrane (vs reference electrode) relates to ion activity by Nernst equation (E = E₀ + (RT/zF)·ln(a)). Glass membrane for Na+/K+/H+; liquid membrane with ionophore for Ca²⁺/Cl⁻; solid-state for F⁻. Direct ISE (whole blood/plasma, POC) avoids dilution; indirect ISE (diluted sample) is affected by pseudohyponatremia from hyperproteinemia/lipemia.

9Pseudohyponatremia occurs in hyperlipidemia or hyperproteinemia when measured by:

A.Direct ISE (whole blood)

B.Indirect ISE (sample diluted before measurement) — falsely low sodium because large lipid/protein fraction reduces water fraction; direct ISE on undiluted sample is not affected

C.Both methods equally

D.Flame photometry not affected

Explanation: Pseudohyponatremia: serum is 93% water normally; severe hyperlipidemia/hyperproteinemia reduces water fraction. Indirect ISE (predilutes sample — e.g., Roche cobas, most benchtop chemistry analyzers) measures concentration per total volume including non-water fraction → falsely low sodium. Direct ISE (undiluted whole blood/plasma — blood gas analyzers, iSTAT) measures activity in the water phase only → true sodium. Osmolar gap is normal. Treat underlying lipid/paraprotein, not the 'hyponatremia'.

10HPLC for hemoglobinopathy detection is:

A.Random

B.Cation-exchange HPLC with pH gradient — separates Hb variants (HbA, HbA2, HbF, HbS, HbC, HbE) by net charge with quantitation; gold standard for HbA2 (thalassemia trait screening)

C.Gas chromatography

D.Mass spec only

Explanation: HPLC cation-exchange separates Hb variants by charge. Provides quantitative HbA2 (elevated in beta-thal trait, typically >3.5%) and HbF (persistent in HPFH, sickle cell with hydroxyurea). Identifies HbS, HbC, HbE, HbD, and others by retention time. Capillary electrophoresis is another high-throughput method. Isoelectric focusing (IEF) provides additional resolution. Sickle solubility confirms HbS qualitatively.

About the ABPath Chemical Pathology Exam

The ABPath Chemical Pathology subspecialty examination certifies pathologists completing a 1-year ACGME-accredited Chemical Pathology fellowship after AP/CP or CP primary certification. It is a one-day computer-based exam at Pearson VUE testing centers with 270 one-best-answer multiple-choice questions in a combined Written/Practical format. Content spans clinical chemistry principles — specimen collection and safety, technical methods (spectrophotometry, ISE, HPLC, electrophoresis, mass spectrometry), analytes, electrolytes/catecholamines/vitamins/porphyrins, toxicology, organ system testing (cardiac, renal, hepatic, pancreatic, bone), endocrine, reproduction/pregnancy/newborn, immunology, and laboratory management. Candidates interpret graphs, chromatograms, electrophoretograms, formulas, and calculations.

Questions

270 scored questions

Time Limit

~6 hours 18 minutes (combined Written/Practical)

Passing Score

Criterion-referenced scaled standard (modified Angoff). Pass/fail determined in single administration.

Exam Fee

$2,100 (ABPath 2026) (American Board of Pathology (ABPath) — administered via Pearson VUE)

ABPath Chemical Pathology Exam Content Outline

14%

Organ Systems

Cardiac: hs-troponin (4th UDMI, 99th percentile + dynamic change), BNP/NT-proBNP rule-out/rule-in (age-adjusted). Renal: CKD-EPI 2021 (race-free), cystatin C, urinalysis (nephritic sediment with RBC casts). Liver: synthetic function (albumin, PT/INR, MELD-Na). Pancreatic: lipase/amylase (Atlanta criteria), fecal elastase-1 for exocrine insufficiency. Bone: BAP/P1NP (formation), CTx/NTx (resorption). Muscle: CK, myoglobin, rhabdomyolysis, anti-HMGCR IMNM.

13%

Analytes

Creatinine (enzymatic preferred; IDMS-traceable), glucose (glycolysis/NaF tube; ADA criteria 126 FPG, 200 OGTT, 6.5% A1c), HbA1c (NGSP+IFCC, altered by RBC lifespan), lipids (Friedewald fails TG >400), bilirubin (conjugated vs unconjugated), ammonia (ice, <30 min), liver enzymes (ALT more specific than AST; AST/ALT >2:1 alcoholic), total CO2 (~HCO3-), anion gap (MUDPILES), osmolar gap (toxic alcohols), ferritin as acute-phase reactant, SAA, procalcitonin, macroenzymes (macro-CK).

11%

Technical Methods

Spectrophotometry (Beer-Lambert A = εbc), direct (undiluted, whole blood, POC) vs indirect (diluted, pseudohyponatremia) ISE by Nernst equation, HPLC cation-exchange for HbA2/HbF/variant quantitation, capillary electrophoresis, SPEP/UPEP/IFE for gammopathies, LC-MS/MS (vitamin D, steroids, immunosuppressants, drugs, newborn screening), electrochemistry, nephelometry/turbidimetry, chromatography, hook effect, heterophile interference (heterophile blockers), biotin interference (FDA 2019 warning).

11%

Electrolytes, Catecholamines, Vitamins, Porphyrins

Na/K/Cl/HCO3, hypokalemia (check Mg, urine K+, acid-base), hypocalcemia (corrected Ca = Ca + 0.8×(4-alb); hypoparathyroidism, vitamin D deficiency, CKD), hypomagnesemia (refractory hypokalemia), hyperphosphatemia (CKD, tumor lysis), acid-base interpretation (Winter formula HCO3×1.5+8±2), plasma free metanephrines (preferred screening for pheochromocytoma — sensitivity >99%), 24-hr urine VMA/HVA (HCl preservation), 25(OH)D by LC-MS/MS (deficiency <20, sufficiency ≥30), B12/folate, iron studies (IDA high TIBC, ACD low TIBC, HH high TSAT/ferritin), porphyrias (AIP with ALA/PBG + Watson-Schwartz, PCT, EPP), lead poisoning (ALA-D/ferrochelatase inhibition → urine ALA + FEP/ZPP + basophilic stippling).

11%

Toxicology

Acetaminophen (Rumack-Matthew nomogram from 4 hr; NAC IV/oral — within 8-10 hr optimal), salicylate (respiratory alkalosis + AG metabolic acidosis; urinary alkalinization + hemodialysis severe), ethylene glycol (osmolar + AG; calcium oxalate crystals; fomepizole), methanol (visual loss, formate; fomepizole + folic acid), carboxyhemoglobin (CO-oximetry, not pulse ox; 100% O2 ± HBO), cyanide (lactate >10 + elevated mixed-venous O2; hydroxocobalamin), digoxin 0.5-0.9 ng/mL (DigiFab), lithium 0.6-1.2, vancomycin AUC/MIC 400-600 or trough 15-20, urine drug screen (misses fentanyl/oxycodone without specific IA; LC-MS/MS confirmation), %CDT for chronic alcohol, cholinesterase for OP/atypical succinylcholine (dibucaine number <30 = atypical homozygote).

11%

Endocrine

TSH-reflex: elevated TSH + low fT4 = primary hypothyroidism (Hashimoto anti-TPO); suppressed TSH + elevated fT4/fT3 = Graves (TSI/TRAb+). Thyroglobulin for thyroid cancer monitoring (watch anti-Tg antibodies). Cushing screening: any 2 of (24-hr UFC, late-night salivary cortisol, 1-mg dex suppression); high-dose dex for pituitary vs ectopic. Primary aldosteronism (ARR >20-30 screen → confirmatory suppression + AVS). Acromegaly (IGF-1 elevated, OGTT non-suppression). Prolactin >200 = macroprolactinoma (hook effect, macroprolactin). Primary hyperparathyroidism (elevated PTH + Ca + 24-hr urine Ca distinguishes FHH). Hypoglycemia workup (insulin + C-peptide + β-HB + sulfonylurea screen). HbA1c ≥6.5% diabetes (ADA). DKA criteria. CAH 17-OHP newborn screening. GSD type I (fasting hypoglycemia + lactic acidosis).

Reproduction, Pregnancy, Newborn

β-hCG normal doubling 48-72 hr (slow rise in ectopic); discriminatory zone 2000-3500 mIU/mL. Second-trimester quad screen (MSAFP, hCG, uE3, inhibin A) for Down/18/NTD. NIPT/cell-free fetal DNA (10+ wk, trisomy 21 sensitivity >99%). Newborn screening RUSP (37 core + 26 secondary): MS/MS acylcarnitines/amino acids for PKU/MSUD/MCAD/etc., enzyme/immunoassay for galactosemia/CH/CAH/HGB/CF/SCID (TREC PCR). AAP 2022 neonatal bilirubin guidelines. Preeclampsia criteria (BP + proteinuria OR end-organ); HELLP. CAH 17-OHP with LC-MS/MS 2nd tier (ratio).

Immunology

Immunoglobulin classes (IgG/A/M/E/D), SPEP fractions (albumin, α1/α2, β1/β2, γ) + polyclonal gammopathy in chronic inflammation, MGUS criteria (<3 g/dL M-protein, <10% plasma cells, no CRAB/SLiM — 1%/year progression). Serum free light chain ratio (κ/λ 0.26-1.65; IMWG SLiM ratio ≥100 with involved FLC >100 mg/L). ANA by HEp-2 IFA (homogeneous/speckled/nucleolar/centromere patterns) — gold standard per ACR. Complement (C3/C4 low in active SLE; C4 low in HAE). ANCA (PR3/MPO antigen-specific; c-ANCA/p-ANCA IFA pattern). Anti-CCP for RA (>95% specificity). Cryoglobulins (warm collection 37°C; type I/II/III). HLA typing by NGS for transplant + SAB for DSA.

Specimen Collection and Safety

OSHA Bloodborne Pathogens Standard 29 CFR 1910.1030 (PPE, exposure control plan, hepatitis B vaccination). Order of draw to prevent carryover (sterile → blue citrate → red/SST → green heparin → lavender EDTA → gray NaF). Tourniquet <1 min (hemoconcentration). Hemolysis elevates K+/LDH/AST/Mg/Ph/Fe. Lipemia interferes spectrophotometrically. Biotin interference in streptavidin-biotin assays (FDA 2019 warning — falsely low sandwich, falsely high competitive; hold biotin 8-72 hr). Pseudohyperkalemia (thrombocytosis/leukocytosis → serum > plasma K+). Pseudohyponatremia (indirect ISE with lipemia/hyperproteinemia). 24-hr urine preservation (HCl for catecholamines/VMA/HVA/metanephrines). Ammonia on ice <30 min.

Laboratory Management

CLIA 1988 test complexity (waived/moderate/high). CAP/AABB accreditation. Westgard multi-rules (1_3s/2_2s/R_4s/4_1s/10_x) on Levey-Jennings charts. CLSI EP28-A3c reference interval (≥120 healthy, 2.5-97.5 percentile; verify transferred with 20). Method validation: EP05 precision, EP09 comparison, EP17 LoD/LoQ, EP07 interferences. PT rules (no referral — CLIA 42 CFR 493.1840 violation; handle as patient samples; 3 events/yr most analytes; 80% pass). FDA 2024 LDT rule (4-yr phase-in of medical device oversight). CAP/AMP NGS validation (Jennings 2017). Biostatistics (sensitivity/specificity/PPV/NPV/ROC/AUC; 120 for RI). LIS/EHR interoperability (LOINC, HL7 FHIR). Billing (CPT 80000-series, 0001U+ PLA, ICD-10 medical necessity, PAMA CLFS).

How to Pass the ABPath Chemical Pathology Exam

What You Need to Know

Passing score: Criterion-referenced scaled standard (modified Angoff). Pass/fail determined in single administration.
Exam length: 270 questions
Time limit: ~6 hours 18 minutes (combined Written/Practical)
Exam fee: $2,100 (ABPath 2026)

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

ABPath Chemical Pathology Study Tips from Top Performers

1Master the Rumack-Matthew nomogram: acetaminophen plotted against time since ingestion (starting at 4 hours post-ingestion); treatment line from 150 μg/mL at 4 hr with declining slope. Above line → NAC IV/oral. Invalid for staggered or chronic ingestion

2Know acid-base with Winter formula: expected PaCO2 = 1.5 × [HCO3] + 8 ± 2 for metabolic acidosis. Anion gap (Na - Cl - HCO3) normal 8-12 (MUDPILES for elevated), osmolar gap >10 suggests unmeasured osmoles (toxic alcohols early)

3Memorize ADA HbA1c ≥6.5% for diabetes diagnosis, using only NGSP-certified and IFCC-traceable methods. HbA1c is unreliable with altered RBC lifespan (hemolysis, transfusion, iron deficiency correction, hemoglobinopathies)

4Know pseudohyponatremia (indirect ISE in lipemia/hyperproteinemia — water-displacement) vs true hyponatremia. Direct ISE (whole blood, POC, iSTAT) measures water-phase activity and is not affected

5Remember biotin interference in streptavidin-biotin immunoassays (FDA 2019 warning): falsely LOW in sandwich format (TSH, fT4, troponin, hCG) and falsely HIGH in competitive format (25-OHD). Hold biotin 8-72 hr before testing

Frequently Asked Questions

What is the ABPath Chemical Pathology subspecialty exam?

The ABPath Chemical Pathology exam is the subspecialty certification examination for pathologists completing a 1-year ACGME-accredited Chemical Pathology fellowship after AP/CP or CP primary certification. It validates expertise in clinical chemistry — analytical and technical methods, interpretation of chemistry/endocrine/toxicology results, specimen handling, organ-specific laboratory assessment, newborn screening, and laboratory management including QC, method validation, and regulatory compliance.

How many questions are on the ABPath Chemical Pathology exam?

The exam contains 270 one-best-answer multiple-choice questions delivered in a combined Written/Practical format. Total testing time is approximately 6 hours 18 minutes delivered in six 45-question combined sections (~63 minutes each, 1.4 minutes per item). Practical questions include graphs, chromatograms, electrophoretograms, calculations (Friedewald, anion gap, osmolar gap, Rumack-Matthew), and interpretation of multiple laboratory results in clinical context.

What is the 2026 ABPath Chemical Pathology blueprint?

The 2026 Chemical Pathology Content Specifications (final 1/2026) allocate: Organ Systems 14%, Analytes 13%, Technical Methods 11%, Electrolytes/Catecholamines/Vitamins/Porphyrins 11%, Toxicology 11%, Endocrine 11%, Reproduction/Pregnancy/Newborn 9%, Immunology 9%, Specimen Collection/Safety 6%, Laboratory Management 5%. The Content Specifications PDF provides a detailed hierarchical topic list with Core/Advanced Resident/Fellow designations.

What are the eligibility requirements for the ABPath Chemical Pathology exam?

Candidates must hold ABPath primary certification in AP/CP or CP and have completed an ACGME-accredited 1-year Chemical Pathology fellowship. Part-time training is acceptable if in an approved ACGME position with duration not exceeding twice the required term. Applicants who completed fellowship ≥10 years ago must complete 12 months of additional ACGME-accredited training. Active unrestricted medical license is required. Applications via PATHway portal February 16 – May 15, 2026.

How much does the ABPath Chemical Pathology exam cost in 2026?

The 2026 ABPath subspecialty exam fee is $2,100, which includes a $200 non-refundable administrative fee. There is no late application fee — applications must be submitted by May 15, 2026 via the PATHway portal. Cancellation by June 15 incurs a $500 cancellation fee; after that date the full fee is forfeited. Retakes require a new application and full $2,100 fee.

When and where is the ABPath Chemical Pathology exam administered?

The 2026 Chemical Pathology subspecialty exam window is September 8 – September 28, 2026, administered at Pearson VUE Professional Testing Centers in the US (limited international locations; exams no longer administered in Quebec, Canada as of 2024). Candidates schedule their own date and location once scheduling opens. The 2027 window is tentatively September 13 – October 2, 2027.

What are the highest-yield topics on the ABPath Chemical Pathology exam?

Analytes + Organ Systems (27% combined) — master glucose/HbA1c standardization, creatinine IDMS, lipids/Friedewald, hs-troponin, BNP, MELD-Na, anion/osmolar gap. Toxicology (11%) — Rumack-Matthew, salicylate acid-base, toxic alcohols (fomepizole), CO-oximetry, TDM (digoxin/lithium/vancomycin). Endocrine (11%) — TSH-reflex, Cushing screening, ARR, cosyntropin, hypoglycemia workup, CAH/17-OHP. Electrolytes/Vitamins/Porphyrins (11%) — acid-base with Winter formula, iron studies, 25(OH)D LC-MS/MS, lead toxicity. Technical Methods (11%) — Beer-Lambert, direct/indirect ISE pitfalls, LC-MS/MS applications, hook and heterophile interference.

How should I study for the ABPath Chemical Pathology exam?

Use the final 2026 ABPath Chemical Pathology Content Specifications PDF (January 2026) as a hierarchical study list. Core references: Tietz Textbook of Clinical Chemistry, Henry's Clinical Diagnosis and Management (Chapter on clinical chemistry), Clinical Chemistry (Burtis), AACC Online courses. Master calculations (anion gap, osmolar gap, Friedewald, Winter formula, Cockcroft-Gault, corrected calcium). Practice interpretation of SPEP/UPEP/IFE, HPLC chromatograms, Rumack-Matthew nomogram. Review LC-MS/MS principles and applications. Take at least 2 timed full-length practice exams in the 2-3 months before the September window.